1. Home
  2. ARQT vs UFPT Comparison

ARQT vs UFPT Comparison

Compare ARQT & UFPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • UFPT
  • Stock Information
  • Founded
  • ARQT 2016
  • UFPT 1963
  • Country
  • ARQT United States
  • UFPT United States
  • Employees
  • ARQT N/A
  • UFPT N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • UFPT Medical/Dental Instruments
  • Sector
  • ARQT Health Care
  • UFPT Health Care
  • Exchange
  • ARQT Nasdaq
  • UFPT Nasdaq
  • Market Cap
  • ARQT 1.7B
  • UFPT 1.8B
  • IPO Year
  • ARQT 2020
  • UFPT 1993
  • Fundamental
  • Price
  • ARQT $13.82
  • UFPT $234.68
  • Analyst Decision
  • ARQT Strong Buy
  • UFPT Buy
  • Analyst Count
  • ARQT 6
  • UFPT 2
  • Target Price
  • ARQT $18.80
  • UFPT $392.00
  • AVG Volume (30 Days)
  • ARQT 1.9M
  • UFPT 285.1K
  • Earning Date
  • ARQT 08-13-2025
  • UFPT 07-29-2025
  • Dividend Yield
  • ARQT N/A
  • UFPT N/A
  • EPS Growth
  • ARQT N/A
  • UFPT 31.41
  • EPS
  • ARQT N/A
  • UFPT 8.15
  • Revenue
  • ARQT $212,819,000.00
  • UFPT $547,560,000.00
  • Revenue This Year
  • ARQT $61.15
  • UFPT $22.16
  • Revenue Next Year
  • ARQT $37.98
  • UFPT $5.60
  • P/E Ratio
  • ARQT N/A
  • UFPT $29.49
  • Revenue Growth
  • ARQT 100.03
  • UFPT 34.43
  • 52 Week Low
  • ARQT $7.86
  • UFPT $178.26
  • 52 Week High
  • ARQT $17.75
  • UFPT $366.41
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 50.73
  • UFPT 50.48
  • Support Level
  • ARQT $12.97
  • UFPT $233.14
  • Resistance Level
  • ARQT $13.84
  • UFPT $250.01
  • Average True Range (ATR)
  • ARQT 0.61
  • UFPT 8.22
  • MACD
  • ARQT 0.02
  • UFPT -0.90
  • Stochastic Oscillator
  • ARQT 51.64
  • UFPT 36.23

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About UFPT UFP Technologies Inc.

UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

Share on Social Networks: